|
Statistics Applied Using Threshold Science Fails to Deliver Progression Toward Truth
|
|
2
|
141
|
September 23, 2021
|
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
2
|
758
|
September 22, 2021
|
|
Probability in state Ps(t) and Hazard ratio HR in Cox model
|
|
1
|
196
|
August 21, 2021
|
|
Logit Rank Plot by J.Copas in rms R package
|
|
6
|
276
|
August 20, 2021
|
|
Resources for Mixed-Effect Models in Medical Contexts
|
|
7
|
533
|
August 8, 2021
|
|
Interactions and random error
|
|
15
|
2439
|
July 17, 2021
|
|
Question arising from JAMA Guide article "Odds Ratios—Current Best Practice and Use"
|
|
19
|
6528
|
July 13, 2021
|
|
Statistical Misinterpretations and Clinical Practice Guidelines: any examples?
|
|
31
|
2530
|
June 28, 2021
|
|
Calculating SMD from geometric mean titers
|
|
2
|
575
|
May 26, 2021
|
|
The distinction between sample description (summarization) and point estimation
|
|
3
|
514
|
May 9, 2021
|
|
Another null misinterpretation in a study about the association of epidural analgesia and offspring risk of autism
|
|
6
|
1337
|
May 1, 2021
|
|
Validation of cox model
|
|
2
|
582
|
April 19, 2021
|
|
Find skewness and kurtosis of a bivariate scatterplot
|
|
1
|
504
|
March 29, 2021
|
|
Is there any intuition for the PRAUC metric?
|
|
0
|
534
|
March 24, 2021
|
|
Recommended Reading: Pay No Atttention to the Model Behind the Curtain by Philip B. Stark
|
|
0
|
652
|
March 11, 2021
|
|
Reporting Generalized Wilcoxon for Survival Analysis
|
|
6
|
1367
|
March 9, 2021
|
|
Musing on how to design "statistical functions/methods 2.0"
|
|
3
|
744
|
March 7, 2021
|
|
Bayesian Re-Analysis of Clinical Trial Data
|
|
19
|
6551
|
March 2, 2021
|
|
Hazard-ratio of marginal effects?
|
|
1
|
623
|
February 17, 2021
|
|
Early use of tocilizumab and steroids does not impact expansion or persistence of CAR T cells in B-ALL?
|
|
2
|
740
|
February 17, 2021
|
|
Interpretation of P value
|
|
4
|
1407
|
December 31, 2020
|
|
Representative Covariate Settings
|
|
2
|
1186
|
December 27, 2020
|
|
Quality of remdesivir trials
|
|
41
|
4941
|
November 18, 2020
|
|
Proper analysis and presentation of the association between a continuous exposure and a binary outcome
|
|
1
|
968
|
November 8, 2020
|
|
Can treatment B be superior after the RCT if it was thought that treatment A is superior before the RCT?
|
|
5
|
1102
|
October 13, 2020
|
|
How to interpret confidence curves?
|
|
2
|
1422
|
September 30, 2020
|
|
Time since randomization and causality
|
|
2
|
947
|
September 27, 2020
|
|
Bayesian Solutions for Challenges to Frequentist Statistics
|
|
0
|
2345
|
September 22, 2020
|
|
Perform Cox PH when KM curves cross
|
|
1
|
1117
|
August 19, 2020
|
|
Thoughts on 'representativeness' and 'generalizability'
|
|
6
|
1717
|
July 19, 2020
|
